NCT01262963 An Absorption, Distribution, Metabolism and Excretion (ADME) Study of Single Oral Dose [14C] GSK2118436 in Subjects With BRAF Mutant Solid Tumors Status COMPLETED Phase PHASE1
NCT01262924 Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine Status COMPLETED Phase PHASE3
NCT01262898 Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis Status COMPLETED Phase PHASE2
NCT01262885 A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT01262872 Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants Status COMPLETED Phase PHASE2
NCT01262820 Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab Status COMPLETED Phase PHASE2
NCT01262469 Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer. Status COMPLETED Phase PHASE2
NCT01260389 Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study. Status COMPLETED Phase NA
NCT01258933 Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy Status TERMINATED Phase PHASE2
NCT01258608 Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT01258530 A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01254071 A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. Status COMPLETED Phase PHASE1
NCT01254032 Predictive Ability of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) for Acute Exacerbations (PACE) in Patients With COPD Status COMPLETED Phase N/A
NCT01254019 A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy Status COMPLETED Phase PHASE3
NCT01253967 Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania Status COMPLETED Phase N/A
NCT01253369 Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01251744 Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus Status COMPLETED Phase NA
NCT01249365 The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study Status COMPLETED Phase PHASE3